Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.29 USD | -6.83% |
|
-21.35% | +31.95% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.95% | 521M | |
+18.15% | 124B | |
+18.02% | 111B | |
-12.75% | 23.17B | |
+5.07% | 22.94B | |
-39.94% | 17.42B | |
-9.86% | 17.42B | |
-14.97% | 16.9B | |
+2.80% | 13.71B | |
+27.39% | 11.82B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Needham Adjusts Price Target on Selecta Biosciences to $4 From $5, Maintains Buy Rating